The Patent Finder

Aurion Biotech, Inc.

Also on record
Records under this name other than the patents Aurion Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 5 of 5 · Back to Aurion Biotech, Inc.

PatentTitleStatus Expires Confidence
US 12,072,334Corneal Endothelial Cell Marker
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,004,707Method for Treating Cancer with Low Molecular Weight Components of Aurin Tricarboxylic Acid Complex
Lapsed on the fee record
Ended Jun 26, 2026 · High confidence
Lapsed on the fee recordEnded Jun 26, 2026High confidence
US 11,013,750Methods for treating and preventing nociceptive pain
Lapsed on the fee record
Ended May 25, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 25, 2025From the USPTO record
US 10,966,945Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic synthetic complex
Lapsed on the fee record
Ended Apr 6, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 6, 2025From the USPTO record
US 10,398,666Method for Treating Cancer with Low Molecular Weight Components of Aurin Tricarboxylic Acid Complex
Lapsed on the fee record
Ended Sep 3, 2023 · High confidence
Lapsed on the fee recordEnded Sep 3, 2023High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited